Latest News
More News
-
Three questions with one of our leading neonatal researchers Dr Tobias Strunk 20 April 2021 Consultant Neonatologist at King Edward Memorial Hospital, Dr Tobias Strunk is a mid-career researcher who is also a Clinical Professor at the University of WA Medical School and Head of Neonatal and Life Course Health at the Telethon Kids Institute. In partnership with Neonatal Immunologist Dr Andrew Currie, Dr Strunk is leading the Neonatal Infection and Immunity Group, a multidisciplinary group that works across a number of institutions. Their work includes leading several large, international cohort studies and clinical trials that focus on identifying new ways to diagnose, prevent and treat infections in the most vulnerable patients, especially those born preterm. Dr Strunk regularly presents at national and international conferences and has received many awards for his work, including from the European Society for Paediatric Infectious Diseases. He is a member of the Perinatal So... -
.png)
Dr Gloria Lau and Dr Anne Sage win Telethon CAHS Research Scholarships 19 April 2021 Two talented clinicians will pursue several research projects following the announcement they have each won a Telethon Child and Adolescent Health Service Research Scholarship. Paediatric Respiratory and General Paediatric Advanced Trainee Dr Gloria Lau will investigate the early detection and effective management of protracted bacterial bronchitis (PBB) in Aboriginal children across multiple locations in WA. Investigating a possible link between otitis media, the most common cause of hearing loss in Aboriginal children, and chronic lung disease in Aboriginal children from Broome will also form part of Dr Lau’s Scholarship. Dr Lau said PBB can be easily missed because the children affected appear to be healthy apart from a wet cough.Untreated PBB can lead to bronchiectasis, an irreversible and life-limiting condition. “PBB is common in Aboriginal children, and early detection... -
Trailblazing Madisen leads the way in new clinical trial offering hope for children with neurofibromatosis 15 April 2021 A six year old Perth girl, Madisen Sotirovska, has become the first patient in Australia and New Zealand to be enrolled in a new clinical trial offering hope to children diagnosed with neurofibromatosis. Perth Children’s Hospital (PCH) Oncology Department is one of several hospitals across Australia and NZ taking part in the TiNT MEK Inhibitor clinical trial that aims to reduce tumour growth caused by neurofibromatosis type 1 (NF1). Neurofibromatosis is a genetic disorder that causes several medical conditions including tumour growth, both benign and cancerous, along the nerves in any part of the body. Madisen’s mum, Angela said neurofibromatosis was a difficult condition to live with because of the uncertainly around when tumours might grow and how they might impact on her daughter. “Madisen currently has tumours growing on her thigh and one on the joints outside o... -
Guidelines signal a new era of care for children with head injuries 13 April 2021 West Australian children, families and emergency department staff have played an important role in the development of Australia and New Zealand’s first set of clinical guidelines to care for children and young people with mild to moderate head injuries. Perth Children’s Hospital (PCH) Emergency Department (ED) staff have worked closely with the Paediatric Research in Emergency Department International Collaborative (PREDICT) network to help develop this definitive guide for emergency department clinicians to diagnose and treat head injuries. The PCH ED guidelines, which cover issues such as patient triage, imaging, transfer, discharge, referrals and follow up, will bring consistency and quality to head injury management across Australia and New Zealand. Emergency physician and Director of Emergency Research, Professor Meredith Borland said PCH ED staff had played a key role i... -
Newborn babies help unlock important insights into gut health 10 February 2021 Lead author and Consultant Neonatologist in the Neonatal Intensive Care Unit (NICU) PCH, Dr Shripada Rao compared the gut bacteria of a group of healthy babies born at King Edward Memorial Hospital to another group of babies with gastrointestinal (GI) surgical conditions who were managed in the NICU at PCH. Comparisons between the two groups were made by analysing stool samples from the babies. The first stool samples were collected soon after birth and the second samples were collected between 10 and 14 days of their life. The study found that during the course of their stay in the NICU, babies with surgical conditions develop more harmful bacteria and lesser amounts of beneficial bacteria in their gut compared to the healthy group of babies. "The findings are significant because they help us understand why these babies often suffer from adverse health following their surgery such as in...
Last Updated:
22/06/2021